secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2024-04-10T23:59:59+00:00
Accession:  0001140361-24-019005
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE prelim Q1 revenue $5.7-5.9M, up 51-56% YoY, highest Q1 ever
--------------------------------------------------------------------

- Preliminary Q1 2024 revenue $5.7M-$5.9M, up 51%-56% vs Q1 2023; highest Q1 in company history.
- UltraMist revenue grew >55% YoY, accounting for ~95% of total revenue.
- UltraMist applicator sales set all-time quarterly record, exceeding 65% of total revenue.
- Full Q1 2024 results expected in mid-May; guidance reaffirmed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124019005/0001140361-24-019005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124019005/ef20026508_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-019005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer